Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells.

Toxicogenomics is a relatively new discipline of toxicology. Microarrays and bioinformatics tools are being used successfully to understand the effects of toxicants on in vivo and in vitro model systems, and to gain a better understanding of the relevance of in vitro models commonly used in toxicological studies. In this study, cDNA filter arrays were used to determine the basal expression patterns of human cultured primary hepatocytes from different male donors; compare the gene expression profile of HepG2 to that of primary hepatocytes; and analyze the effects of three genotoxic hepatocarcinogens; aflatoxin B(1) (AFB(1)), 2-acetylaminofluorene (2AAF), and dimethylnitrosamine (DMN), as well as one non-gentoxic hepatotoxin, acetaminophen (APAP) on gene expression in both in vitro systems. Real-time PCR was used to verify differential gene expression for selected genes. Of the approximately 31,000 genes screened, 3-6% were expressed in primary hepatocytes cultured on matrigel for 16 h. Of these genes, 867 were expressed in cultured hepatocytes from all donors. HepG2 cells expressed about 98% of the genes detectable in cultured primary hepatocytes, however, 31% of the HepG2 transcriptome was unique to the cell line. A number of these genes are expressed in human liver but expression is apparently lost during culture. There was considerable variability in the response to chemical carcinogen exposure in primary hepatocytes from different donors. The transcription factors, E2F1 and ID1 mRNA were increased three-fold and six-fold (P < 0.05, P < 0.01), respectively, in AFB(1) treated primary human hepatocytes but were not altered in HepG2. ID1 expression was also increased by dimethylnitrosamine, acetylaminofluorene and acetaminophen in both primary hepatocytes and HepG2. Identification of genes that are expressed in primary hepatocytes from most donors, as well as those genes with variable expression, will aid in understanding the variability in human reactions to drugs and chemicals. This study suggests that identification of biomarkers of exposure to some chemicals may be possible in the human through microarray analysis, despite the variability in responses.

[1]  W. Forrester,et al.  Inhibition of an Erythroid Differentiation Switch by the Helix-Loop-Helix Protein Id1 (*) , 1995, The Journal of Biological Chemistry.

[2]  N. Takai,et al.  Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma. , 2001, Cancer letters.

[3]  T. Balla Pharmacology of phosphoinositides, regulators of multiple cellular functions. , 2001, Current pharmaceutical design.

[4]  L. Yamasaki Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action. , 1999, Biochimica et biophysica acta.

[5]  A. Kasza,et al.  Long-term culture of HepG2 hepatoma cells as a model for liver acute phase response during chronic inflammation. Effects of interleukin-6, dexamethasone and retinoic acid. , 1994, Biological chemistry Hoppe-Seyler.

[6]  V. Misra,et al.  Different cellular localization, translocation, and insulin‐induced phosphorylation of PKBα in HepG2 cells and hepatocytes , 2002, Journal of cellular biochemistry.

[7]  H. Yamazaki,et al.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  P. Schirmacher,et al.  Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. , 1992, Cancer research.

[9]  C. Bréchot,et al.  Insulin-like growth factor II (IGF-II) mRNA expression during hepatocarcinogenesis in transgenic mice. , 1991, Journal of hepatology.

[10]  J. Essigmann,et al.  Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. , 1982, Drug metabolism reviews.

[11]  I. Screpanti,et al.  Differential regulation of E2F1 apoptotic target genes in response to DNA damage , 2003, Nature Cell Biology.

[12]  H. Kleinman,et al.  Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix , 1988, Journal of cellular physiology.

[13]  J. Gauldie,et al.  Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. , 1987, Journal of immunology.

[14]  M. A. Hayes,et al.  Comparative cytopathology of primary rat hepatocyte cultures exposed to aflatoxin B1, acetaminophen, and other hepatotoxins. , 1985, Toxicology and applied pharmacology.

[15]  C. Bréchot,et al.  Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis. , 1990, Journal of hepatology.

[16]  K. Kunii,et al.  Type II Phosphatidylinositol 4-Kinase β Is a Cytosolic and Peripheral Membrane Protein That Is Recruited to the Plasma Membrane and Activated by Rac-GTP* , 2002, The Journal of Biological Chemistry.

[17]  K. Yamada,et al.  Diacylglycerol kinase: a key modulator of signal transduction? , 1990, Trends in biochemical sciences.

[18]  B E Butterworth,et al.  Use of primary cultures of human hepatocytes in toxicology studies. , 1989, Cancer research.

[19]  M. Bissell,et al.  Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1 , 1995, Molecular and cellular biology.

[20]  N. Javitt Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Keiko Yamada,et al.  Alternative Splicing of the Human Diacylglycerol Kinase δ Gene Generates Two Isoforms Differing in Their Expression Patterns and in Regulatory Functions* , 2002, The Journal of Biological Chemistry.

[22]  J. Enghild,et al.  Biosynthesis of Bikunin Proteins in the Human Carcinoma Cell Line HepG2 and in Primary Human Hepatocytes , 1995, The Journal of Biological Chemistry.

[23]  William S. Ball,et al.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. , 2001, American journal of human genetics.

[24]  P. De Camilli,et al.  Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Richert,et al.  Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines , 2000, Human & experimental toxicology.

[26]  Kun Wang,et al.  Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. , 2002, The Journal of toxicological sciences.

[27]  Thierry Lavé,et al.  Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. , 2002, Biochemical pharmacology.

[28]  R. Wanders,et al.  Peroxisomal enzyme activities in the human hepatoblastoma cell line HepG2 as compared to human liver. , 1991, Biochimica et biophysica acta.

[29]  W. Pan,et al.  Analysis by cDNA microarrays of altered gene expression in middle ears of rats following pneumococcal infection. , 2002, International journal of pediatric otorhinolaryngology.

[30]  S. Sarraj,et al.  Reconstitution of dna synthetic capacity in senescent normal human fibroblasts by expressing cellular factors E2F and Mdm2. , 2001, Experimental cell research.

[31]  R G Ulrich,et al.  Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. , 2001, Toxicology letters.

[32]  G. Everson,et al.  Bile acid synthesis in cultured human hepatoblastoma cells. , 1991, The Journal of biological chemistry.

[33]  J. Castell,et al.  Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells , 1998 .

[34]  S. Thorgeirsson,et al.  Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis , 2000, Oncogene.

[35]  T. Südhof,et al.  A Novel Family of Phosphatidylinositol 4-Kinases Conserved from Yeast to Humans* , 2001, The Journal of Biological Chemistry.

[36]  A. Klein-Szanto,et al.  E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. , 2000, Cancer research.

[37]  J. Campisi,et al.  Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. , 1994, The Journal of biological chemistry.

[38]  D. Schrenk,et al.  Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures. , 1995, Carcinogenesis.

[39]  D. Ginsberg,et al.  ATM is a target for positive regulation by E2F-1 , 2003, Oncogene.

[40]  O. Sugita,et al.  Drug metabolism by the human hepatoma cell, Hep G2. , 1987, Biochemical and biophysical research communications.

[41]  D. Tuma,et al.  Establishment of a recombinant hepatic cell line stably expressing alcohol dehydrogenase. , 1995, Archives of biochemistry and biophysics.

[42]  T. K. Baker,et al.  Temporal gene expression analysis of monolayer cultured rat hepatocytes. , 2001, Chemical research in toxicology.

[43]  Silvio Albertini,et al.  Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  N. Plant,et al.  Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[45]  Masakazu Ueda,et al.  TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas , 2002, Hepatology.

[46]  M. P. Carrasco,et al.  Evidence of differential effects produced by ethanol on specific phospholipid biosynthetic pathways in rat hepatocytes , 1996, British journal of pharmacology.

[47]  R. W. Niessen,et al.  The Influence of Insulin, ß-Estradiol, Dexamethasone and Thyroid Hormone on the Secretion of Coagulant and Anticoagulant Proteins by HepG2 Cells , 1995, Thrombosis and Haemostasis.

[48]  R. Fisher,et al.  Expression and inducibility of the human bilirubin UDP‐glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: Evidence for both genetic and environmental influences , 1999, Hepatology.

[49]  R. Stevenson,et al.  X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. , 2002, American journal of human genetics.

[50]  I. White,et al.  Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts. , 2000, Carcinogenesis.

[51]  D. Barlow,et al.  Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. , 1999, Genomics.

[52]  W. Hong,et al.  Overexpression of E2F‐1 in rat embryo fibroblasts leads to neoplastic transformation. , 1994, The EMBO journal.

[53]  C. Wolf,et al.  Induction of drug metabolizing enzymes in human liver cell line Hep G2 , 1985, FEBS letters.

[54]  Incorporation of exogenous precursors into neutral lipids and phospholipids in rat hepatocytes: effect of ethanol in vitro. , 1998, Biochemical pharmacology.

[55]  Jie Liu,et al.  Stress-related gene expression in mice treated with inorganic arsenicals. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[56]  K. Polonsky,et al.  Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. , 1990, The Journal of clinical investigation.

[57]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.

[58]  M. Grant,et al.  Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. , 1988, Biochemical pharmacology.

[59]  R. Edwards,et al.  Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[60]  D. Ginsberg,et al.  E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress* , 2003, The Journal of Biological Chemistry.

[61]  R. Heller,et al.  Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. , 2003, The American journal of pathology.

[62]  N. L. La Thangue,et al.  A new component of the transcription factor DRTF1/E2F , 1993, Nature.

[63]  Heinz Bönisch,et al.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 , 2002, British journal of pharmacology.

[64]  M. Honda,et al.  α‐fetoprotein‐producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis , 2001 .

[65]  K. Iyer,et al.  Characterization of Phase I and Phase II hepatic drug metabolism activities in a panel of human liver preparations. , 1999, Chemico-biological interactions.

[66]  M. P. Carrasco,et al.  Resistance of HepG2 cells against the adverse effects of ethanol related to neutral lipid and phospholipid metabolism. , 2002, Biochemical pharmacology.

[67]  J. Brady,et al.  Expression profiling of acetaminophen liver toxicity in mice using microarray technology. , 2001, Biochemical and biophysical research communications.

[68]  S. Langouet,et al.  Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones. , 1993, Cancer research.

[69]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[70]  J. Hsuan,et al.  Cloning of a Human Type II Phosphatidylinositol 4-Kinase Reveals a Novel Lipid Kinase Family* , 2001, The Journal of Biological Chemistry.

[71]  S. R. Nash,et al.  Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. , 1994, Receptors & channels.

[72]  J. Pevsner,et al.  Microarray analysis of differential gene expression in lead-exposed astrocytes. , 2001, Toxicology and applied pharmacology.